"The AG-702 is in analysis since about Oct. 04 when the last patient was
finished in Portland. There is no intention to go on to Phase ll with
this formulation, atleast as far as I know. They are looking at other
possible formulations. I/we do not have that information."
This was from a scientist at the University of Washington. Hopefully,
Antigenics is now working on their AG-707, which is the successor to
AG-702.
How are you finding all of this out?
Angela :)

Signature
STD Message Board:
http://www.yoshi2me.com/ipw-web/bulletin/bb/index.php
Picking Up the Pieces:
http://health.groups.yahoo.com/group/PickingUpThePieces/
> "The AG-702 is in analysis since about Oct. 04 when the last patient was
> finished in Portland. There is no intention to go on to Phase ll with
[quoted text clipped - 4 lines]
> Antigenics is now working on their AG-707, which is the successor to
> AG-702.
Anonymous - 14 Dec 2004 00:10 GMT
> How are you finding all of this out?
>
> Angela :)
Email is a wonderful tool, when used correctly ;-)
They (University of Washington) have been very helpful.
Angela S. - 14 Dec 2004 12:32 GMT
Well... thanks for sharing what you know.. I personally appreciate it very
much. :-)
Angela :-)

Signature
STD Message Board:
http://www.yoshi2me.com/ipw-web/bulletin/bb/index.php
Picking Up the Pieces:
http://health.groups.yahoo.com/group/PickingUpThePieces/
>> How are you finding all of this out?
>>
[quoted text clipped - 3 lines]
>
> They (University of Washington) have been very helpful.